Association Editor
Chenlu Zhu
- M.D./Ph.D.
- Cerebral Atherosclerosis and Migraine Researcher
- zhuchl20@163.com
- First Affiliated Hospital of Shandong First Medical University
Research Field
- Pathogenesis of Cerebral Atherosclerosis and Migraine
- Advanced Techniques for Investigating Brain Diseases
- Identification of New Clinical Treatment Targets
Biography
Dr. Chenlu Zhu is a dedicated researcher specializing in the clinical and fundamental mechanism research of cerebral atherosclerosis and migraine at the First Affiliated Hospital of Shandong First Medical University. His work aims to elucidate the pathogenesis of these conditions by integrating clinical data with basic animal experiments, providing important insights into their diagnosis and treatment.
He is proficient in identifying clinical problems and exploring answers through advanced techniques such as mouse behavioral analysis, two-photon microscopy, animal MRI experiments and analysis, electrophysiology, optogenetics, and chemogenetics, to investigate the neural circuits involved in brain diseases. Dr. Zhu has published more than 20 high-impact research articles as a first author and co-author in well-known international and domestic journals, with a cumulative impact factor exceeding 40.
Active in the academic community, Dr. Zhu has participated in numerous conferences, submitting papers and engaging in scholarly communication. He holds various academic positions, including young editorial board member of Medicine Advances, editorial board member of Chinese Journal of Neurosurgical Disease Research, editorial board member of Life Conflux, associate editor of Brain Conflux, and invited reviewer for several international journals such as Neural Regeneration Research, Scientific Reports, Frontiers in Neurology, Science Development, and SN Comprehensive Clinical Medicine.
Dr. Zhu's ongoing work continues to drive the development of neuroscience research at the First Affiliated Hospital of Shandong First Medical University. His ultimate goal is to clarify the pathogenesis of cerebral atherosclerosis and migraine and identify new targets for clinical treatment.
Journal Information
- Journal: Brain Conflux
- Online ISSN: 3079-6016
- Publisher: Life Conflux Press Limited
- Peer Review: Single-anonymous
- Publication Model: Open Access
- Publishing Frequency: Quarterly
- Languages: English
- DOI Prefix: 10.71321
Submit Your Research
Fast-track peer review process
Journal Metrics
Impact factors & citation analysis
Research Areas
Clinical Neurology
Neuroimaging
Neurobiology
Neurosurgery
Psychiatry
Pediatric Neurology
AI in Neuroscience
Bioinformatics
Epidemiology
Geriatrics
Neuro-oncology
And many more specialized fields within brain sciences and medicine
For Authors & Reviewers
Publication Statistics
~28 days
Average Review Time
94%
Author Satisfaction
72%
Acceptance Rate
Global
Author Network
Open Access Benefits
✓
Immediate global accessibility
✓
No subscription barriers
✓
Enhanced citation potential
✓
Maximum research impact
Brain Conflux promotes open science principles, ensuring that groundbreaking research in life sciences and medicine reaches the global scientific community without barriers, accelerating scientific discovery and innovation.
Creative Commons License
Brain Conflux operates under a Creative Commons Attribution 4.0 International License, enabling unrestricted use, distribution, and reproduction while ensuring proper attribution to original authors and research integrity.
Copyright & Author Rights
Authors retain full copyright ownership of their work while granting Brain Conflux the right to publish and distribute. All submissions must comply with our rigorous ethical standards and originality requirements. Published content becomes freely accessible to the global research community, promoting scientific advancement and knowledge sharing.
Key Requirements: Original research, ethical compliance, proper citations, and agreement to publication terms.
Publication Ethics
Brain Conflux maintains the highest standards of publication ethics, preventing plagiarism, ensuring research integrity, and upholding international best practices. We implement comprehensive screening processes and follow COPE (Committee on Publication Ethics) guidelines to maintain scientific credibility.
Ethical Standards
COPE Certified
Digital Object Identifier
Every article receives a unique DOI through Crossref registration, ensuring permanent digital identification, reliable citation tracking, and long-term content preservation. This enhances discoverability and supports accurate academic referencing across global databases.
Recent Issues
